位置:首页 > 蛋白库 > NADA_BACSU
NADA_BACSU
ID   NADA_BACSU              Reviewed;         368 AA.
AC   Q9KWZ1; O32063;
DT   11-JUL-2002, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2002, sequence version 2.
DT   03-AUG-2022, entry version 119.
DE   RecName: Full=Quinolinate synthase {ECO:0000255|HAMAP-Rule:MF_00569, ECO:0000303|PubMed:18959769};
DE            EC=2.5.1.72 {ECO:0000255|HAMAP-Rule:MF_00569, ECO:0000269|PubMed:18959769};
GN   Name=nadA {ECO:0000255|HAMAP-Rule:MF_00569, ECO:0000303|PubMed:18959769};
GN   OrderedLocusNames=BSU27850;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168;
RA   Tosato V., Bolotin A., Bertani I., Valentino I., Bruschi C.V.;
RT   "A 17.8 kb segment in the spoVB-nadC region of the Bacillus subtilis 168
RT   chromosome: sequencing and ruv operon identification.";
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V.,
RA   Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R.,
RA   Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S.,
RA   Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K.,
RA   Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F.,
RA   Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D.,
RA   Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M.,
RA   Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P.,
RA   Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K.,
RA   Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S.,
RA   Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y.,
RA   Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G.,
RA   Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M.,
RA   Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y.,
RA   Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J.,
RA   Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A.,
RA   Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M.,
RA   Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S.,
RA   Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E.,
RA   Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES,
RP   PATHWAY, SUBUNIT, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF CYS-82; CYS-110;
RP   CYS-230; CYS-259; CYS-318 AND CYS-320.
RX   PubMed=18959769; DOI=10.1111/j.1742-4658.2008.06641.x;
RA   Marinoni I., Nonnis S., Monteferrante C., Heathcote P., Haertig E.,
RA   Boettger L.H., Trautwein A.X., Negri A., Albertini A.M., Tedeschi G.;
RT   "Characterization of L-aspartate oxidase and quinolinate synthase from
RT   Bacillus subtilis.";
RL   FEBS J. 275:5090-5107(2008).
CC   -!- FUNCTION: Catalyzes the condensation of iminoaspartate with
CC       dihydroxyacetone phosphate to form quinolinate. {ECO:0000255|HAMAP-
CC       Rule:MF_00569, ECO:0000269|PubMed:18959769}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dihydroxyacetone phosphate + iminosuccinate = H(+) + 2 H2O +
CC         phosphate + quinolinate; Xref=Rhea:RHEA:25888, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29959, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57642, ChEBI:CHEBI:77875; EC=2.5.1.72;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00569,
CC         ECO:0000269|PubMed:18959769};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:25889;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00569,
CC         ECO:0000269|PubMed:18959769};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00569,
CC         ECO:0000269|PubMed:18959769};
CC       Note=Binds 1 [4Fe-4S] cluster per subunit. {ECO:0000255|HAMAP-
CC       Rule:MF_00569, ECO:0000269|PubMed:18959769};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.36 mM for dihydroxyacetone phosphate
CC         {ECO:0000269|PubMed:18959769};
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; quinolinate from
CC       iminoaspartate: step 1/1. {ECO:0000255|HAMAP-Rule:MF_00569,
CC       ECO:0000269|PubMed:18959769}.
CC   -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:18959769}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00569}.
CC   -!- DISRUPTION PHENOTYPE: Mutant requires exogenous nicotinic acid for
CC       growth. {ECO:0000269|PubMed:18959769}.
CC   -!- SIMILARITY: Belongs to the quinolinate synthase family. Type 3
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_00569}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB75321.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y15896; CAB75321.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL009126; CAB14745.1; -; Genomic_DNA.
DR   PIR; E69663; E69663.
DR   RefSeq; NP_390663.1; NC_000964.3.
DR   RefSeq; WP_003229691.1; NZ_JNCM01000036.1.
DR   AlphaFoldDB; Q9KWZ1; -.
DR   SMR; Q9KWZ1; -.
DR   IntAct; Q9KWZ1; 1.
DR   MINT; Q9KWZ1; -.
DR   STRING; 224308.BSU27850; -.
DR   PaxDb; Q9KWZ1; -.
DR   PRIDE; Q9KWZ1; -.
DR   DNASU; 937522; -.
DR   EnsemblBacteria; CAB14745; CAB14745; BSU_27850.
DR   GeneID; 937522; -.
DR   KEGG; bsu:BSU27850; -.
DR   PATRIC; fig|224308.179.peg.3026; -.
DR   eggNOG; COG0379; Bacteria.
DR   InParanoid; Q9KWZ1; -.
DR   OMA; CFCSTMN; -.
DR   PhylomeDB; Q9KWZ1; -.
DR   BioCyc; BSUB:BSU27850-MON; -.
DR   UniPathway; UPA00253; UER00327.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008987; F:quinolinate synthetase A activity; IBA:GO_Central.
DR   GO; GO:0034628; P:'de novo' NAD biosynthetic process from aspartate; IBA:GO_Central.
DR   Gene3D; 3.40.50.10800; -; 3.
DR   HAMAP; MF_00569; NadA_type3; 1.
DR   InterPro; IPR003473; NadA.
DR   InterPro; IPR036094; NadA_sf.
DR   InterPro; IPR023515; Quinolinate_synth_A_type3.
DR   PANTHER; PTHR30573; PTHR30573; 1.
DR   Pfam; PF02445; NadA; 1.
DR   SUPFAM; SSF142754; SSF142754; 1.
DR   TIGRFAMs; TIGR00550; nadA; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Cytoplasm; Iron; Iron-sulfur; Metal-binding;
KW   Pyridine nucleotide biosynthesis; Reference proteome; Transferase.
FT   CHAIN           1..368
FT                   /note="Quinolinate synthase"
FT                   /id="PRO_0000155816"
FT   BINDING         46
FT                   /ligand="iminosuccinate"
FT                   /ligand_id="ChEBI:CHEBI:77875"
FT                   /evidence="ECO:0000250|UniProtKB:O57767, ECO:0000255|HAMAP-
FT                   Rule:MF_00569"
FT   BINDING         63
FT                   /ligand="iminosuccinate"
FT                   /ligand_id="ChEBI:CHEBI:77875"
FT                   /evidence="ECO:0000250|UniProtKB:O57767, ECO:0000255|HAMAP-
FT                   Rule:MF_00569"
FT   BINDING         110
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00569,
FT                   ECO:0000269|PubMed:18959769"
FT   BINDING         141..143
FT                   /ligand="iminosuccinate"
FT                   /ligand_id="ChEBI:CHEBI:77875"
FT                   /evidence="ECO:0000250|UniProtKB:O57767, ECO:0000255|HAMAP-
FT                   Rule:MF_00569"
FT   BINDING         162
FT                   /ligand="iminosuccinate"
FT                   /ligand_id="ChEBI:CHEBI:77875"
FT                   /evidence="ECO:0000250|UniProtKB:O57767, ECO:0000255|HAMAP-
FT                   Rule:MF_00569"
FT   BINDING         230
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00569,
FT                   ECO:0000269|PubMed:18959769"
FT   BINDING         256..258
FT                   /ligand="iminosuccinate"
FT                   /ligand_id="ChEBI:CHEBI:77875"
FT                   /evidence="ECO:0000250|UniProtKB:O57767, ECO:0000255|HAMAP-
FT                   Rule:MF_00569"
FT   BINDING         273
FT                   /ligand="iminosuccinate"
FT                   /ligand_id="ChEBI:CHEBI:77875"
FT                   /evidence="ECO:0000250|UniProtKB:O57767, ECO:0000255|HAMAP-
FT                   Rule:MF_00569"
FT   BINDING         320
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00569,
FT                   ECO:0000269|PubMed:18959769"
FT   MUTAGEN         82
FT                   /note="C->S: No change in activity and in iron content."
FT                   /evidence="ECO:0000269|PubMed:18959769"
FT   MUTAGEN         110
FT                   /note="C->S: Loss of activity. Does not bind iron. Cannot
FT                   complement the deletion mutant."
FT                   /evidence="ECO:0000269|PubMed:18959769"
FT   MUTAGEN         230
FT                   /note="C->S: Loss of activity. Does not bind iron. Cannot
FT                   complement the deletion mutant."
FT                   /evidence="ECO:0000269|PubMed:18959769"
FT   MUTAGEN         259
FT                   /note="C->S: No change in activity and in iron content."
FT                   /evidence="ECO:0000269|PubMed:18959769"
FT   MUTAGEN         318
FT                   /note="C->S: No change in activity and in iron content.
FT                   Cannot complement the deletion mutant. Lacks activity and
FT                   does not binds iron; when associated with S-320."
FT                   /evidence="ECO:0000269|PubMed:18959769"
FT   MUTAGEN         320
FT                   /note="C->S: Loss of activity. Decreases iron binding.
FT                   Cannot complement the deletion mutant. Lacks activity and
FT                   does not binds iron; when associated with S-318."
FT                   /evidence="ECO:0000269|PubMed:18959769"
SQ   SEQUENCE   368 AA;  41493 MW;  7F2E428C69B8A567 CRC64;
     MSILDVIKQS NDMMPESYKE LSRKDMETRV AAIKKKFGSR LFIPGHHYQK DEVIQFADQT
     GDSLQLAQVA EKNKEADYIV FCGVHFMAET ADMLTSEQQT VVLPDMRAGC SMADMADMQQ
     TNRAWKKLQH IFGDTIIPLT YVNSTAEIKA FVGKHGGATV TSSNAKKVLE WAFTQKKRIL
     FLPDQHLGRN TAYDLGIALE DMAVWDPMKD ELVAESGHTN VKVILWKGHC SVHEKFTTKN
     IHDMRERDPD IQIIVHPECS HEVVTLSDDN GSTKYIIDTI NQAPAGSKWA IGTEMNLVQR
     IIHEHPDKQI ESLNPDMCPC LTMNRIDLPH LLWSLEQIEK GEPSGVIKVP KAIQEDALLA
     LNRMLSIT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024